A meta-analysis examining 27 studies conducted between the years 2007 and 2015 demonstrated a pooled sensitivity of 0.62 (95% confidence intervals (CI), 0.51–0.72) and 0.96 (95% CI 0.93–0.98) for specificity in EGFR genotyping in NSCLC [49]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.